Bachir Taouli, MD
img_Bachir Taouli
PROFESSOR | Diagnostic, Molecular and Interventional Radiology
PROFESSOR | Medicine
Are you a patient?
Specialties
Radiology, Body Imaging
Research Topics
Cancer, Eye Movements, Liver, Magnetic Resonance Imaging, Mathematical Modeling of Biomedical Systems
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Cancer Biology [CAB], Disease Mechanisms and Therapeutics (DMT)
Non invasive detection of liver fibrosis and cirrhosis with MRI
MRI is a versatile technique, with no radiation exposure, and the possibility of performing multiparametric imaging. One of the interesting applications of MRI is the non invasive detection of liver damage caused by hepatitis and other insults, usually assessed with liver biopsy. Dr Taouli's experience using diffusion and perfusion MRI showed potential usefulness for detection of liver fibrosis and cirrhosis. MR elastography is also an emerging technique that will soon be offered routinely to patients with liver disease at Mount Sinai.
Assessment of liver cancer with advanced MRI methods
Primary liver cancer (hepatocellular carcinoma: HCC) can be treated aggressively when diagnosed early, using for example hepatic resection of transplantation. Imaging plays a pivotal role in the detection of hepatocellular carcinoma. MRI is especially attractive as it is radiation free and can be easily repeated in patients with liver disease on a regular basis. One of Dr Taouli's research interests is to characterize liver tumors in terms of aggressiveness, angiogenesis and oxygen delivery through the use of advanced MRI methods.
HCC screening using abbreviated MRI
An abbreviated MRI protocol (less than 15 min acquisition time) using a liver specific agent such as gadoxetic acid has the potential to improve liver cancer detection compared to standard ultrasound. We have started a prospective research protocol comparing the abbreviated MRI to ultrasound for HCC screening in patients with cirrhosis.
Assessment of prostate cancer with MRI
MRI is the primary modality used for prostate cancer detection and staging. One of Dr Taouli's research interests is the use of multiparametric MRI to better detect and stage prostate cancer, and assess and predict response to radiation therapy.
Prediction of the degree of portal hypertension in patients with cirrhosis
The goal of this study is to develop non invasive tools based on MR elastography and phase-contrast 4D flow imaging of the liver and spleen as biomarkers of portal pressure in patients with chronic liver disease.
Radiogenomics of HCC using qualitative and quantitative MRI
The goal of this study is to develop and validate robust and reproducible qualitative and quantitative MRI-signatures of genomic aberrations of HCC, and that ultimately predict response to molecular targeted therapies, enabling personalized management of HCC patients.

MD, s60637

Residency, Pediatrics, University of Algiers

Residency, Radiology, General, Jean-Verdier Hospital

Residency, Diagnostic Imaging, University Pierre Et Marie Curie Paris 6 Medical Studies (France)

Fellowship, Radiology, General, University of California San Francisco

Certifications

American Board of Radiology

2017

Magna Cum Laude Merit Award for abstract

ISMRM

2017

Magna Cum Laude Merit Award for abstract

ISMRM

2017

Best Translational Research/Dose Scientific Paper Award for abstract

Society of Abdominal Radiology,

2016

Distinguished reviewer

J Magn Reson Imaging

2016

Distinguished Investigator

Academy of Radiology Research

2014

Summa Cum Laude Merit Award

ISMRM meeting

2013

Student award

Radiology Society North America

2013

Fellow of the Society of Abdominal Radiology

FSAR

2012

Best Paper-First time presenter

SGR meeting

2012

Magna Cum Laude Merit Award

ISMRM meeting

2012

Distinguished reviewer

J Magn Reson Imaging

2011

Keynote Lecture

10th International Symposium on High Field MRI

2008

Research award

Society of Uroradiology

2007

Scholarship Grant

Radiological Society of North America

2004

Research Award

Society of Gastrointestinal Radiologists

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Taouli during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bayer Healthcare Pharmaceuticals
  • Worldcare Clinical
  • Guerbet, France

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.